The Advanced Oncology/Hematology Drug Development Fellowship Program is designed for medical oncologists who desire additional fellowship training and clinical experience in clinical research with particular emphasis on early drug development methodology.
Institute of Drug Development fellows learn the clinical management of patients with advanced malignancies receiving treatment on Phase I clinical trials. This will include documentation necessary for clinical research subjects, the ethical aspects and regulatory process of informed consent as well as the capture of data including understanding the common toxicity criteria used in toxicity assessment. Our alumni are performing translational research into new drug development.
The training gave me a behind-the-scenes look at the logistics required to organize, oversee and execute successful clinical trials. The experience and skills I learned are invaluable in my clinical practice.
Desiree Hao, Medical Oncology, Tom Baker Cancer Centre Associate Professor, Department of Oncology, University of Calgary